Search

Craig J Beavers,1 Youssef Bessada,2 Rachel Bond,3 Kristen Veneman,4 Geoffery D Barnes5 1Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY, USA; 2Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, CT, USA; 3BHMG Cardiology Mercy Gilbert, Gilbert, AZ, USA; 4Elliot Vascular Surgery, Elliot Hospital, Manchester, NH, USA; 5Frankel Cardiovascular Center, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USACorrespondence: Craig J Beavers, Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, 789 South Limestone Street, Lexington, KY, USA, Tel +1 859-983-0393, Email cjbeav2@uky.eduAbstract: Lower extremity peripheral artery disease (PAD) is a common atherosclerotic cardiovascular disease (ASCVD) involving the aortoiliac, femoropopliteal, and infrapopliteal arterial segments. PAD remains a largely underdiagnosed and undertreated condition. The ankle-brachial index (ABI) is a simple and widely available test that is key detection tool in the diagnosis of PAD and is prognostic for mortality and morbidity. The cardiovascular (CV) team is a diverse array of health care clinicians (eg, nurses, nurse practitioners, physician assistants/associates, pharmacists, podiatrists) who have the qualifications and skills to be able to recognize when patients are at risk for PAD and perform an ABI. It is critical that the healthcare community recognize the critical role the CV team could play in improving outcomes and reducing disparities for patients with PAD.Keywords: atherosclerotic cardiovascular disease, team-based care, ankle-brachial index, health disparities

Sally G Barnes, Bailey Sutliff, Michael P Wendel, Everett F Magann Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, Little Rock, AR, USACorrespondence: Everett F Magann, Department of Obstetrics and Gynecology, University of Arkansas for Medical Sciences, 4301 W. Markham St. Slot #518, Pulaski County, Little Rock, AR, 72205, USA, Tel +1-501-686-8345, Fax +1-501-526-7820, Email efmagann@uams.eduObjective: This review examines the initial development of a transport system for neonates, followed by a subsequent evolution of a transportation system for the maternal/fetal unit, and then a maternal transport system (antepartum, intrapartum, and postpartum) to specifically address maternal morbidity/mortality.Methods: A literature search was undertaken using the electronic databases PubMed, Embase, and CINAHL. The search terms used were “maternal transport” AND “perinatal care” OR “labor” “obstetrics” OR “delivery”. The years searched were 1960– 2023.Results: There were 260 abstracts identified and 52 of those are the basis of this review. The utilization of a transportation system with the regionalization of levels of care has resulted in a significant reduction in neonatal, perinatal, and maternal morbidity and mortality. Although preterm delivery remains a concern in women transported, the number of deliveries that have occurred during transport is relatively small. Reimbursement for transportation continues to be a problem in several states.Conclusion: A state-of-the-art transportation system has evolved that transfers neonates, maternal/fetal dyad, and pregnant women (antepartum, intrapartum, postpartum) to the appropriate level of care facility to ensure the best maternal/fetal/neonatal outcomes.Keywords: maternal transport, maternal morbidity/mortality, perinatal morbidity/mortality, levels of care, pregnancy

We provide a simple method that enables readily acquired experimental data to be used to predict whether or not a candidate molecular material may exhibit strong coupling. Specifically, we explore the relationship between the hybrid molecular/photonic (polaritonic) states and the bulk optical response of the molecular material. For a given material, this approach enables a prediction of the maximum extent of strong coupling (vacuum Rabi splitting), irrespective of the nature of the confined light field. We provide formulae for the upper limit of the splitting in terms of the molar absorption coefficient, the attenuation coefficient, the extinction coefficient (imaginary part of the refractive index) and the absorbance. To illustrate this approach, we provide a number of examples, and we also discuss some of the limitations of our approach.